ArticleFrontiers in immunology2025

Beyond tumor mutation burden: tumor neoantigen burden as a superior prognostic biomarker in resected gastric cancer.

Tingting Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.